In the print version of the Table of Contents above [J Pharmacol Exp Ther vol. 302, no. 1], the title of the article on page 352 by Shapiro et al. was misprinted. The correct title is “Putative Conventional Protein Kinase C Inhibitor Gödecke 6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3,a)pyrrolo(3,4-c)-carbazole] Stimulates Transglutaminase Activity in Primary Mouse Epidermal Keratinocytes”, and the online version has been corrected.
Also, for the article entitled “(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-2′-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a Selective and Orally Active Inhibitor of Tumor Necrosis Factor-α Convertase” on page 390, the complete list of authors in the Table of Contents should be G. Beck, G. Bottomley, D. Bradshaw, M. Brewster, M. Broadhurst, R. Devos, C. Hill, W. Johnson, H.-J. Kim, S. Kirtland, J. Kneer, N. Lad, R. Mackenzie, R. Martin, J. Nixon, G. Price, A. Rodwell, F. Rose, J.-P. Tang, D. S. Walter, K. Wilson, and E. Worth, and the online version has been corrected.
We apologize for any inconvenience caused by these printer errors.
- The American Society for Pharmacology and Experimental Therapeutics